Literature DB >> 27644618

Global Prostate Cancer Incidence and Mortality Rates According to the Human Development Index.

Salman Khazaei1, Shahab Rezaeian, Erfan Ayubi, Behzad Gholamaliee, Mahin Ahmadi Pishkuhi, Somayeh Khazaei, Kamyar Mansori, Shahrzad Nematollahi, Mohadeseh Sani, Shiva Mansouri Hanis.   

Abstract

BACKGROUND: Prostate cancer (PC) is one of the leading causes of death, especially in developed countries. The human development index (HDI) and its dimensions seem correlated with incidence and mortality rates of PC. This study aimed to assess the association of the specific components of HDI (life expectancy at birth, education, gross national income per 1000 capita, health, and living standards) with burden indicators of PC worldwide.
MATERIALS AND METHODS: Information of the incidence and mortality rates of PC was obtained from the GLOBOCAN cancer project in year 2012 and data about the HDI 2013 were obtained from the World Bank database. The correlation between incidence, mortality rates, and the HDI parameters were assessed using STATA software.
RESULTS: A significant inequality of PC incidence rates was observed according to concentration indexes=0.25 with 95% CI (0.22, 0.34) and a negative mortality concentration index of -0.04 with 95% CI (-0.09, 0.01) was observed.
CONCLUSIONS: A positive significant correlation was detected between the incidence rates of PC and the HDI and its dimensions including life expectancy at birth, education, income, urbanization level and obesity. However, there was a negative significant correlation between the standardized mortality rates and the life expectancy, income and HDI.

Entities:  

Mesh:

Year:  2016        PMID: 27644618

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Prostate cancer clinical characteristics and outcomes in Central Sudan.

Authors:  Sami Mahjoub Taha; Hsin-Yi Weng; Mohammed El Imam Mohammed; Yassin M Osman; N'sanh N'dri; Sulma I Mohammed; Dafalla Omer Abuidris
Journal:  Ecancermedicalscience       Date:  2020-10-06

2.  Identification of SPOP related metabolic pathways in prostate cancer.

Authors:  Min Yan; Huan Qi; Jia Li; Guozhu Ye; Yaping Shao; Tongming Li; Jing Liu; Hai-Long Piao; Guowang Xu
Journal:  Oncotarget       Date:  2017-10-03

3.  Relationship between the Human Development Index and its Components with Oral Cancer in Latin America.

Authors:  Brenda Yuliana Herrera-Serna; Edith Lara-Carrillo; Victor Hugo Toral-Rizo; Regiane Cristina do Amaral; Raul Alberto Aguilera-Eguía
Journal:  J Epidemiol Glob Health       Date:  2019-12

Review 4.  The incidence of prostate cancer in Iran: a systematic review and meta-analysis.

Authors:  Soheil Hassanipour; Mohammad Fathalipour; Hamid Salehiniya
Journal:  Prostate Int       Date:  2017-12-08

5.  Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway in vivo.

Authors:  Yi Chen; Nan Chen; Jin Xu; Xindong Wang; Xiaowei Wei; Cuiju Tang; Zhong Duanmu; Junfeng Shi
Journal:  Aging (Albany NY)       Date:  2021-08-27       Impact factor: 5.682

6.  Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Rama Jayaraj; Greg Raymond; Sunil Krishnan; Katherine S Tzou; Siddhartha Baxi; M Ravishankar Ram; Suresh Kumar Govind; Harish C Chandramoorthy; Faisal N Abu-Khzam; Peter Shaw
Journal:  Cancers (Basel)       Date:  2020-05-09       Impact factor: 6.639

7.  Is the press properly presenting the epidemiological data on COVID-19? An analysis of newspapers from 25 countries.

Authors:  Luciano Serpa Hammes; Arthur Proença Rossi; Luana Giongo Pedrotti; Paulo Márcio Pitrez; Mohamed Parrini Mutlaq; Regis Goulart Rosa
Journal:  J Public Health Policy       Date:  2021-08-02       Impact factor: 2.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.